- Canagliflozin should be taken once daily, typically in the morning, with or without food. It is important to drink plenty of fluids throughout the day to prevent dehydration, as the drug has diuretic effects.
- Metformin should be taken with meals to help prevent gastrointestinal side effects. It is often started at a low dose and gradually increased to minimize stomach upset.
Combination Tablets:
- Fixed-dose combination tablets of canagliflozin and metformin (e.g., Invokamet) are available for patients who need both drugs. These tablets combine the standard doses of both medications, simplifying the dosing regimen and improving patient adherence.
Missed Dose: If a dose of either medication is missed, it should be taken as soon as remembered unless it is close to the time for the next dose. In such cases, the missed dose should be skipped, and the regular dosing schedule resumed.
- Canagliflozin: Canagliflozin is an SGLT2 inhibitor. SGLT2 is a protein in the kidneys that reabsorbs glucose from the urine back into the bloodstream. By inhibiting this transporter, canagliflozin helps to excrete excess glucose through urine, thereby lowering blood sugar levels. Additionally, canagliflozin has mild diuretic effects, which may help reduce blood pressure.
Metformin: Metformin is a biguanide medication. It works by improving insulin sensitivity in the body, helping muscle and liver cells respond better to insulin. It also reduces the amount of glucose produced by the liver and decreases intestinal absorption of glucose. This helps lower blood sugar levels without causing excessive insulin release or hypoglycemia (low blood sugar), making it one of the first-line treatments for type 2 diabetes.
While the combination of canagliflozin and metformin is generally well-tolerated, there are potential side effects associated with each medication.
Canagliflozin side effects:
- Genital infections: An increased risk of genital and urinary tract infections, as glucose in the urine can promote bacterial and fungal growth.
- Dehydration: Due to its diuretic effect, canagliflozin may cause dehydration, leading to symptoms like dizziness, lightheadedness, and fainting.
- Low blood pressure: Canagliflozin may lower blood pressure, which can be problematic for individuals who are already taking blood pressure-lowering medications.
- Kidney problems: Kidney function may be impaired with canagliflozin, particularly in patients with pre-existing kidney conditions.
- Diabetic ketoacidosis (DKA): Rarely, canagliflozin can cause diabetic ketoacidosis, a serious condition where the body produces high levels of ketones, leading to acidosis.
Metformin side effects:
- Gastrointestinal issues: Metformin can cause nausea, diarrhea, abdominal discomfort, or a metallic taste, especially when starting the medication or increasing the dose.
- Lactic acidosis: This is a rare but serious side effect of metformin, particularly in patients with impaired kidney function, liver disease, or other risk factors for acidosis.
Vitamin B12 deficiency: Long-term use of metformin may reduce vitamin B12 absorption, leading to deficiency in some people.
- Canagliflozin: Starting dose is typically 100 mg once daily, which may be increased to 300 mg depending on the patient’s response and tolerance.
- Metformin: The usual starting dose is 500 mg once or twice daily, with gradual increases based on tolerance, up to a maximum of 2000–2500 mg per day.
Combination products like Invokamet provide fixed doses, such as 100 mg of canagliflozin and 500 mg of metformin in a single tablet, simplifying the treatment regimen for patients.
Canagliflozin and metformin are both prescription medications, and a healthcare provider must prescribe them. The combination may be prescribed as a single tablet (e.g., Invokamet) or as two separate medications. Regular monitoring of kidney function, blood glucose levels, and overall health is necessary during treatment with this combination.